Also trades as: BSL.SI (SES) · $vol 2M

$0.64

+0.00 (+0.00%)

OTC · Healthcare · Medical - Care Facilities · Tech Score Sell · Power 45 · $1.2B mcap · 773M float · 0.0000% daily turnover · Short 66% of daily vol

Revenue

$765M +1.8% ▲

5Y CAGR: +6.1%

Gross Profit

$137M -71.9% ▼

5Y CAGR: -20.6%

Operating Income

$91M +10.6% ▲

5Y CAGR: +0.6%

Net Income

$71M +13.3% ▲

5Y CAGR: +1.4%

EPS (Diluted)

$0.04 +14.1% ▲

5Y CAGR: +1.3%

EBITDA

$135M -0.9% ▼

5Y CAGR: +1.5%

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$724M	$823M	$708M	$752M	$765M
YoY Growth	+27.4%	+13.7%	-14.0%	+6.1%	+1.8%
Cost of Revenue	$143M	$127M	$392M	$265M	$628M
Gross Profit	$581M	$640M	$316M	$486M	$137M
Gross Margin	80.2%	77.8%	44.6%	64.7%	17.9%
R&D Expenses	$0	$0	$0	$0	$0
SG&A Expenses	$42M	$104M	$142M	$0	$51M
Operating Expenses	$458M	$205M	$200M	$404M	$45M
Operating Income	$121M	$196M	$116M	$82M	$91M
Operating Margin	16.8%	23.8%	16.3%	11.0%	11.9%
Interest Expense	$6M	$7M	$6M	$6M	$4M
Income Before Tax	$116M	$192M	$119M	$87M	$94M
Tax Expense	$32M	$48M	$28M	$25M	$23M
Net Income	$84M	$143M	$90M	$62M	$71M
Net Margin	11.6%	17.4%	12.7%	8.3%	9.2%
EPS (Diluted)	$0.04	$0.08	$0.05	$0.03	$0.04
EBITDA	$161M	$236M	$133M	$136M	$135M
Shares Outstanding	1.88B	1.87B	1.87B	1.86B	1.85B

Line Item	FY2024 Q1	FY2024 Q2	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2026 Q1	FY2026 Q2
Revenue	$183M	$183M	$193M	$193M	$189M	$189M	$177M	$177M
Cost of Revenue	$101M	$101M	$106M	$106M	$102M	$102M	$99M	$99M
Gross Profit	$82M	$82M	$87M	$87M	$87M	$87M	$77M	$77M
Gross Margin	44.9%	44.9%	45.2%	45.2%	45.9%	45.9%	43.9%	43.9%
R&D Expenses	$0	$0	$0	$0	$0	$0	$0	$0
SG&A Expenses	$42M	$42M	$43M	$43M	$45M	$45M	$41M	$41M
Operating Expenses	$61M	$61M	$67M	$67M	$66M	$66M	$58M	$58M
Operating Income	$21M	$21M	$21M	$21M	$21M	$21M	$19M	$19M
Operating Margin	11.3%	11.3%	10.7%	10.7%	11.0%	11.0%	10.8%	10.8%
Interest Expense	$0	$3M	$0	$0	$0	$0	$0	$0
Income Before Tax	$22M	$22M	$22M	$22M	$22M	$22M	$20M	$20M
Tax Expense	$6M	$6M	$6M	$6M	$6M	$6M	$5M	$5M
Net Income	$15M	$15M	$16M	$16M	$16M	$16M	$15M	$15M
Net Margin	8.4%	8.4%	8.2%	8.2%	8.5%	8.5%	8.2%	8.2%
EPS (Diluted)	$0.01	$0.01	$0.01	$0.01	$0.01	$0.01	$0.01	$0.01
EBITDA	$30M	$30M	$28M	$28M	$31M	$31M	$30M	$30M
Shares Outstanding	1.89B	1.89B	1.86B	1.86B	1.86B	1.86B	1.84B	1.84B

RAFLF OTC